Antidote / Resuscitation
Pregnancy: C - use in life-threatening LAST; benefit clearly outweighs risk
Lipid Emulsion 20% (Intralipid)
Brand names: Intralipid 20%, ClinOleic 20%
Adult dose
Dose: Bolus: 1.5 mL/kg IV over 1 min; Infusion: 0.25 mL/kg/min for 30-60 min
Route: IV
Frequency: Repeat bolus x2 at 5-min intervals if cardiovascular collapse persists; max cumulative 10-12 mL/kg
For local anaesthetic systemic toxicity (LAST): give bolus immediately on cardiac arrest. Maintain infusion for at least 10 min after haemodynamic stability achieved.
Paediatric dose
Dose: 1.5 mL/kg
Route: IV
Frequency: Same protocol as adult
Max: 10 mL/kg cumulative
Same weight-based dosing. Monitor for fat overload syndrome.
Dose adjustments
Renal
Not applicable - emergent antidote use.
Paediatric weight-based calculator
Same weight-based dosing. Monitor for fat overload syndrome.
Clinical pearls
- First-line treatment for local anaesthetic systemic toxicity (LAST): bupivacaine > levobupivacaine > ropivacaine > lidocaine toxicity.
- Mechanism: 'lipid sink' - sequesters lipophilic local anaesthetic molecules from cardiac and CNS tissue.
- Also used for toxicity from: tricyclic antidepressants, verapamil, diltiazem, beta-blockers, lamotrigine - off-label but guideline-supported.
- AAGBI LAST guidelines: have Intralipid available in every area where regional anaesthesia is performed.
- Do not use propofol as a substitute - insufficient lipid content and cardiorespiratory depression.
- Continue CPR throughout infusion - lipid works during ongoing resuscitation.
Contraindications
- Severe egg or soy allergy (soybean oil base) - relative; benefit outweighs risk in cardiac arrest
- Severe hyperlipidaemia
- Fat overload syndrome
Side effects
- Fat overload syndrome (rare at standard doses)
- Pancreatitis (rare)
- Interference with blood tests (lipid interference in serum samples)
- Venous thrombophlebitis at infusion site
Interactions
- Interferes with pulse oximetry and laboratory results - obtain samples before infusion if possible
- Propofol: contains lipid - do not confuse with therapeutic agent
Monitoring
- Continuous ECG
- BP every 2-5 min
- Neurological status
- Serum lipids post-resuscitation
- Liver function 24-48 h post-use
Reference: BNFc; AAGBI LAST Guidelines 2023; TOXBASE; ACMT Position Statement 2022; BNF 84. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Parkland Formula for Burns Fluid Resuscitation · Burns
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- GO-FAR Score for Post-CPR Survival · Resuscitation
- CART Score for Cardiac Arrest Risk Triage · Resuscitation
- RESCUE-IHCA Score for ECPR in In-Hospital Cardiac Arrest · Cardiac Arrest
- CAHP Score (Cardiac Arrest Hospital Prognosis) · Resuscitation
Pathways
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
- Syncope Assessment · ESC 2018 Syncope Guidelines; NICE NG109
- Acute Chest Pain · NICE CG95; ESC 2023 ACS Guidelines